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Abstract
Background: Inspiratory occlusion evoked cortical potentials (the respiratory related-evoked
potentials, RREPs) bear witness of the processing of changes in respiratory mechanics by the brain.
Their impairment in children having suffered near-fatal asthma supports the hypothesis that relates
asthma severity with the ability of the patients to perceive respiratory changes. It is not known
whether or not chronic respiratory defects are associated with an alteration in brain processing of
inspiratory loads. The aim of the present study was to compare the presence, the latencies and the
amplitudes of the P1, N1, P2, and N2 components of the RREPs in children with chronic lung or
neuromuscular disease.
Methods: RREPs were recorded in patients with stable asthma (n = 21), cystic fibrosis (n = 32),
and neuromuscular disease (n = 16) and in healthy controls (n = 11).
Results: The 4 RREP components were significantly less frequently observed in the 3 groups of
patients than in the controls. Within the patient groups, the N1 and the P2 components were
significantly less frequently observed in the patients with asthma (16/21 for both components) and
cystic fibrosis (20/32 and 14/32) than in the patients with neuromuscular disease (15/16 and 16/16).
When present, the latencies and amplitudes of the 4 components were similar in the patients and
controls.
Conclusion: Chronic ventilatory defects in children are associated with an impaired cortical
processing of afferent respiratory signals.
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Background
Repeated inspiratory occlusions applied at the mouth in
humans elicit cortical potentials, usually referred to as res-
piratory-related evoked potentials (RREPs) [1], which rep-
resent one of the respiratory counterparts of
somatosensory evoked potentials. These potentials fea-
ture a sequence of components reflecting the arrival of
impulses at the primary sensory cortex and, for the later
components, the cortical processing of the information
[1,2]. The first positive component, P1, occurs 40–60 ms
after the beginning of the load-related change in mouth
pressure. Its amplitude is determined mainly by the phys-
ical characteristics of the stimuli [3]. P1 is followed by a
negative component N1 (average latency 80 ms), and by
later components positive and negative again (P2, and
N2). Inspiratory occlusions also elicit later components
occurring circa 300 ms after the stimulus which seem to
have a cognitive nature [4].
The afferent sources of the RREPs are likely to be multiple
and redundant, and mechanoreceptors located within the
airways, the lung, the chest wall and the respiratory mus-
cles seem to all contribute to the RREPs. For example, the
RREPs are present in bilateral lung transplant recipients,
namely in spite of bilateral vagotomy [4]. The upper air-
ways mechanoreceptors probably also play an important
role in the generation of the RREPs [5], but these poten-
tials can still be observed in their absence [6]. The RREPs
are unaltered by acute inspiratory muscle fatigue [7] and
they are present, even though incomplete and abnormal,
in patients with severe inspiratory pump dysfunction [8].
Of note, if in such patients, the upper airway is bypassed,
the RREPs disappear [8].
Within this frame, chronic abnormalities of the respira-
tory system, either intrinsic or neuromuscular in origin,
could alter the RREPs. The present study tested this
hypothesis, by comparing the RREPs in children with
asthma, cystic fibrosis (CF), and neuromuscular disease.
This question is clinically relevant. Indeed, there are par-
allels between some characteristics of the RREPs and the
ability to perceive inspiratory resistive loads [9] and esti-
mate their magnitude [3,10]. The documentation of the
RREPs in patients with respiratory defects could provide
an objective estimate of their capacity to detect changes in
respiratory mechanics, a capacity that has been shown to
have a prognostic value in certain settings. Indeed, in chil-
dren with a history of life-threatening asthma, inspiratory
resistive load detection has been shown to be blunted [11]
as it has been observed in adults [12]. Also the aptitude of
these patients to estimate the magnitude of inspiratory
resistive loads may be impaired [13], and has been shown
to be associated with highly abnormal RREPs [14]. We
observed also very recently that RREPs components were
less frequently observed in children with asthma as com-
pared to healthy pediatric and adult subjects [15]. The aim
of the present study was thus to compare RREPs in chil-
dren with asthma, CF, and neuromuscular disease.
Methods
Patients
The study was conducted in agreement with the French
regulations and had received appropriate legal and ethical
approval (Comité Consultatif de Protection des Person-
nes se prêtant à des Recherches Biomédicales de l'Hôpital
Saint Antoine, Paris, France). The patients and their par-
ents gave written informed consent. The patients were
recruited on a consecutive basis from our hospital ward
and outpatient clinic, and were included in the study if 1)
they had been clinically stable for at least one month; 2)
they were able to perform reproducible lung function tests
within the 24 hours preceding the study; 3) they had a
transcutaneous oxyhemoglobin saturation (SpO2) above
90%; and 4) they did not receive any kind of neurotropic
substance.
The patients belonged to three categories, neuromuscular
disease (n = 16), asthma (n = 21), and CF (n = 32) (Table
1). The group of neuromuscular patients included 10 boys
with Duchenne muscular dystrophy, 4 girls with spinal
muscular amyotrophy, and 2 girls with Becker muscular
dystrophy. Four patients (3 patients with Duchenne mus-
cular dystrophy and one patient with spinal muscular
amyotrophy) required nocturnal noninvasive positive
pressure ventilation.
Both the asthma and CF groups were constituted of
patients with varying degrees of severity, ranging from
"mild" to "severe". For asthma, the "mild" phenotype was
defined as a clinical and functional control without
inhaled corticosteroids and the "severe" phenotype as the
presence of permanent symptoms despite treatment and/
or a history of near-fatal asthma. For CF, the "mild" phe-
notype was defined as a forced expiratory volume in one
second (FEV1) ≤ 45% predicted and the "severe" pheno-
type as a FEV1 = 45% predicted. The majority of these
patients participated to a previous study on RREPs [15].
Eleven healthy children also participated (RREPs meas-
urement only) (Table 1). They were free of any known res-
piratory or neurological disease.
Lung function data
Forced vital capacity (FVC), FEV1, functional residual
capacity, measured by the helium dilution technique
(FRC He) and by plethysmography (FRC Pl) were meas-
ured. The resistance of the respiratory system (Rrsint) was
calculated [16]. SpO2 and arterial blood gases were also
measured [17,18].Respiratory Research 2007, 8:61 http://respiratory-research.com/content/8/1/61
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Respiratory-related evoked potentials
The patients and the controls were instructed to avoid
sleep deprivation during the 48 hours preceding the
recording of RREPs, and to eat lightly on the study day.
They were studied during wakefulness, sitting on a lounge
chair with the back, neck and head comfortably sup-
ported. They were asked to relax, and wore headphones
through which they listened to a quiet musical piece of
their choice, in order to mask the auditory ambiance of
the laboratory. The children, wearing a noseclip, breathed
room air through a flanged mouthpiece and a heated
pneumotachograph (Hans Rudolph, Kansas city, MO)
connected to a ± 2 cm H2O linear pressure transducer
(Validyne, Northridge, CA) in order to measure ventila-
tory flow. Mouth pressure was measured from a side port
of the mouthpiece, using a differential pressure transducer
(DP 15–32 Validyne). The pneumotachograph was
assembled in series to a nonrebreathing two way valve
(2600 series, Hans Rudolph) of which the inspiratory port
could be occluded by an inflatable balloon (9340 series
occlusion valve and 9330 series compressor, Hans
Rudolph). The inspiratory airflow detected by the pneu-
motachograph was transmitted to a command box (Neu-
roservices, Savigny sur Orge, France) that triggered the
occlusion valve. Each occlusion stimulus started 250 ms
after the onset of the inspiration defined as flow reversal
and lasted 400 ms; the average pressure change was 3.6 ±
0.4 cm H2O [15]. Occluded breaths were separated by two
to six unoccluded breaths.
Evoked responses to occlusions were recorded using
standard surface electrodes placed on the scalp at C3 and
C4, and Cz according to the international 10–20 system
[19]. The ground electrode was placed on the left mastoid
process. Electrodes impedances were checked at regular
intervals and maintained below 5 kOhms. The signals
from left (C3-Cz) and right (C4-Cz) parietal areas were sep-
arately recorded from 350 ms before to 400 ms after the
occlusion stimulus (Viking Select, Nicolet, Madison, WI).
The signal was amplified at a 5000 Hz rate over a 1–250
Hz bandwidth. A given occluded breath was retained for
averaging only in the presence of a stable electroencepha-
lographic signal baseline and in the absence of obviously
aberrant accidents. Evoked responses to 80 consecutive
occlusions were averaged [14].
The RREPs were manually analysed. The presence or
absence of the first positive (P1), first negative (N1), sec-
ond positive (P2), and second negative (N2) components
of the RREPs were noted. The latencies and baseline to
peak amplitudes of the components were measured
according to Davenport et al. [14]. Amplitudes were also
measured from peak to peak [15].
Statistical analysis
Right-to-left comparisons of the presence of the various
components of the RREPs were conducted within the con-
trols and within each category of patients using the McNe-
mar test. Right-to-left comparisons of the amplitudes and
latencies of the various components of the RREPs were
conducted within the controls and each category of
patients using the Wilcoxon signed rank sum test. The
controls were compared to the pooled patients using the
Student t test or Chi-squared test where appropriate. For
Table 1: Characteristics of the controls and the patients.
Controls n = 11 P (controls vs 
pooled patients)
Patients with 
asthma n = 21
Patients with 
cystic fibrosis n = 
32
Patients with 
neuromuscular 
disease n = 16
P (between the 
patient groups)
Male/Female 5/6 NS 12/9 16/16 12/4 NS
Age (years) 12 ± 3 NS 12 ± 3 13 ± 4 12 ± 3 NS
Weight (kg) 51 ± 12 0.008 40 ± 13 37 ± 11# 44 ± 7 < 0.001
Height (cm) 158 ± 18 0.006 144 ± 15 145 ± 18 146 ± 19 NS
FVC (% Pred) NP NP 98 ± 15§ 67 ± 26 52 ± 22 < 0.0001
FEV1 (% Pred) NP NP 92 ± 16§ 56 ± 28 57 ± 25 < 0.0001
FRC He (% Pred) NP NP 105 ± 20 98 ± 24 82 ± 32 NS
FRC Pl (% Pred) NP NP 125 ± 20 165 ± 40 NP < 0.05
SpO2 (%) NP NP 97 ± 2 94 ± 3 98 ± 1 NS
Rsint (% Pred) NP NP 160 ± 21 217 ± 85 183 ± 60 NS
Data are presented as mean ± SD.
Abbreviations: FVC: vital capacity; FEV1: forced expiratory volume in one second; FRC He: functional residual capacity by the helium technique; 
FRC Pl: functional residual capacity measured by plethysmography, SpO2: transcutaneous oxyhemoglobin saturation, Rsint: airway resistance by the 
interruption technique, % Pred: values are expressed as a percentage of predicted value. # height is expressed as the armspan in neuromuscular 
patients.
The controls were compared to the pooled patients using the Student t test or Chi-squared test where appropriate. Comparison between the 3 
groups of patients was performed with the Kruskal Wallis rank sum test. #Weight was significantly lower in the patients with cystic fibrosis 
compared to the other patients. §The asthmatic patients had a significantly better lung function than the two other groups, no significant differences 
were observed between patients with cystic fibrosis and those with neuromuscular disease. NP: not performed, NS: not significant.Respiratory Research 2007, 8:61 http://respiratory-research.com/content/8/1/61
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each component of the RREPs considered in a dichoto-
mous manner (present vs. absent), the three categories of
patients were compared using the Fisher's exact test. For
quantitative variables, comparisons between the 3 groups
of patients were conducted using the Kruskall-Wallis rank
sum test. In all analyses, differences were considered sig-
nificant when the probability p of a type I error was 5% or
less. Values are reported as mean ± SD.
Results
Patients and controls
The age and gender distribution were similar in the con-
trols and the 3 groups of patients but the controls had a
significantly greater height and weight than the patients
(Table 1). Mean weight was significantly lower in the
patients with CF compared to the patients with asthma
and neuromuscular disease. Mean FVC and FEV1 were sig-
nificantly lower in the patients with CF and neuromuscu-
lar diseases than in the patients with asthma. No
difference was observed between the 3 categories of
patients for mean FRC He, SpO2 and Rsint (Table 1), but
FRC Pl was significantly increased in patients with CF
compared to the asthmatic patients.
Presence and characteristics of the RREPs components
All the components of the RREPs were present on both
sides in 100% of the control subjects (Table 2), with nor-
mal latencies (data not shown) and expected baseline to
peak amplitudes (Table 3). Peak to peak amplitudes were
also within the normal range (data not shown). An exam-
ple of RREPs is shown in Figure 1.
The 4 components of the RREPs were significantly less fre-
quently observed in the patients than in the controls
(Table 2 and Figure 2). Within the 3 groups of patients,
the N1 and the P2 components were significantly less fre-
quently observed in the patients with CF than in the
patients with asthma or a neuromuscular disease. How-
ever, the P1 and the N2 component were observed with a
similar frequency in the 3 groups. The complete P1-N1-
P2-N2 sequence was observed in only 2 patients with
moderate asthma, in 3 patients with CF with moderate
lung disease, and in 3 patients with neuromuscular dis-
eases. The RREPs lacked completely in 3 asthmatic
patients (which was not significantly different from con-
trol subjects and neuromuscular patients) and 12 patients
with CF (which was a significantly higher proportion than
in any of the other groups, p = 0.012). These 3 asthmatic
patients and 12 patients with CF did not differ from the
other patients within their group, either with regard to
their clinical presentation, or with regard to their lung
function.
Individual example of a patient with Duchenne muscular dys- trophy showing the 4 components of the respiratory related  evoked potential following inspiratory airway occlusion Figure 1
Individual example of a patient with Duchenne muscular dys-
trophy showing the 4 components of the respiratory related 
evoked potential following inspiratory airway occlusion. 
Traces represent from top to bottom: left (C3-Cz) response, 
right (C4-Cz) response, and real time mouth pressure. S: 
onset of occlusion stimulus.
N2
P2
N1
P1
S
10 µV 
75 ms
C3 - Cz 
C4 - Cz 
Occlusion
Table 2: Presence of the different components of the respiratory-related evoked potentials (RREPs) in the controls and the patients 
with asthma, cystic fibrosis, and neuromuscular diseases.
RREP components Controls n = 11 P (controls vs 
pooled patients)
Patients with 
asthma n = 21
Patients with 
cystic fibrosis n = 
32
Patients with 
neuromuscular 
disease n = 16
P (between the 
patient groups)
P1 (Cz-C3) 11 0.003 12 14 12 NS
P1 (Cz-C4) 1 10 . 0 11 3 1 7 1 3 N S
N1 (Cz-C3) 11 0.0002 14 17 16 # 0.07
N1 (Cz-C4) 1 10 . 0 21 6 2 01 5  # 0 . 0 0 2
P2 (Cz-C3) 11 0.0001 13 12 14 # 0.003
P2 (Cz-C4) 11 0.00001 16 14 16 # 0.0001
N2 (Cz-C3)1 1 0 . 0 0 4 9 1 4 8 N S
N2 (Cz-C4) 11 0.003 10 13 10 NS
The controls were compared to the pooled patients using the Student t test or Chi-squared test where appropriate. Comparison between the 3 
groups of patients was made using the Fisher's exact test. #Significant differences were observed between the patients with neuromuscular disease 
and the two other groups, no differences were observed between patients with cystic fibrosis and asthma.Respiratory Research 2007, 8:61 http://respiratory-research.com/content/8/1/61
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For all the 4 components, when present, the latencies were
similar in the controls and the 3 categories of patients
(data not shown).
Table 3 shows the baseline to peak amplitudes of the 4
components. The only significant difference was a greater
amplitude of the N1 component in the controls (mean
5.46 ± 3.84 µV) compared to the pooled patients (mean
2.73 ± 1.77 µV, p = 0.02). The peak to peak amplitudes
were comparable among the controls and the pooled
patients, and within the 3 patient groups (data not
shown).
No qualitative or quantitative right-to-left difference was
detected (Table 2).
Discussion
The four main components of the RREPs were signifi-
cantly less frequent in children with stable chronic lung
and airway diseases or with a ventilatory defect of neu-
romuscular origin than in age-matched healthy controls.
This suggests that chronic ventilatory defects in children
can be associated with an impaired cortical processing of
afferent respiratory signals. In addition, the RREPs abnor-
malities were more pronounced in asthmatic children and
in children with CF than in children with a ventilatory
defect due to a neuromuscular disease. Indeed, the N1 and
P2 components were significantly less frequently seen in
the patients with asthma or CF, and the number of
patients exhibiting no RREPs at all was significantly
greater in the CF group.
Physiological considerations
The CF patients enrolled in this study were comparable to
those evaluated in previous studies [20,21]. The respira-
tory mechanics of these patients is characterized by an
increase in the work of breathing as assessed by the high
values of inspiratory and diaphragmatic pressure time
products. This elevated work of breathing is the signature
of a chronically augmented mechanical load, with an elas-
tic component attested by the presence of dynamic hyper-
inflation and a resistive component in line with the
chronic, irreversible, airflow obstruction. Breathing
against an elevated background resistance increases the
threshold for detection of an added resistance [22]. Yet it
has been shown that this also reduces the amplitude of
the RREPs elicited by the sudden application of a resistive
load [6]. In fact, RREPs elicited by an additional resistance
are present only if this resistance exceeds the value of the
detection threshold [6]. The increase in background load
could thus explain why the RREPs were more abnormal in
the CF patients than in the other patient groups. However,
Table 3: Baseline to peak amplitudes of the different components of the respiratory-related evoked potentials (RREPs) in the controls 
and the patients with asthma, cystic fibrosis, neuromuscular diseases.
RREPs component 
amplitudes (µV)
Controls n = 11 P (controls vs 
pooled patients)
Patients with 
asthma n = 21
Patients with 
cystic fibrosis n = 
32
Patients with 
neuromuscular 
diseases n = 16
P (between the 
patient groups)
P1 (Cz-C3) 3.07 ± 2.07 NS 0.94 ± 0.61 1.54 ± 1.11 1.81 ± 1.28 NS
P1 (Cz-C4) 3.07 ± 2.07 NS 1.12 ± 0.72 1.25 ± 0.85 1.21 ± 0.72 NS
N1 (Cz-C3) 5.46 ± 3.84 0.03 2.21 ± 1.48 3.00 ± 2.51 3.83 ± 2.39 NS
N1 (Cz-C4) 5.46 ± 3.84 0.02 2.02 ± 1.13 2.97 ± 2.28 3.21 ± 1.90 NS
P2 (Cz-C3) 2.15 ± 1.57 NS 1.25 ± 1.42 2.10 ± 1.54 3.00 ± 1.90 NS
P2 (Cz-C4) 2.15 ± 1.57 NS 1.54 ± 1.21 1.81 ± 1.14 1.33 ± 0.82 NS
N2 (Cz-C3) 2.39 ± 1.42 NS 1.11 ± 0.75 1.64 ± 0.87 2.75 ± 2.05 NS
N2 (Cz-C4) 2.39 ± 1.42 NS 2.17 ± 1.53 1.75 ± 1.11 2.91 ± 2.36 NS
Data are presented as mean ± DS. The controls were compared to the pooled patients using the Student t test or Chi-squared test where 
appropriate Comparison between the 3 patient groups was made using the Kruskal Wallis rank sum test.
Individual example of a patient with congenital muscular dys- trophy of unknown origin showing only the N1 component  of the respiratory related evoked potential following inspira- tory airway occlusion Figure 2
Individual example of a patient with congenital muscular dys-
trophy of unknown origin showing only the N1 component 
of the respiratory related evoked potential following inspira-
tory airway occlusion. The P1 component is not reproduci-
ble. Traces represent from top to bottom: left (C3-Cz) 
response, right (C4-Cz) response, and real time mouth pres-
sure. S: onset of occlusion stimulus.
N1
S
10 µV 
75 ms
C3 - Cz 
C4 - Cz 
OcclusionRespiratory Research 2007, 8:61 http://respiratory-research.com/content/8/1/61
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we did not study resistance-elicited RREPs, but rather
occlusion-induced ones. By definition, and except if the
capacity to detect a resistance is totally abolished, the infi-
nite resistance that corresponds to an inspiratory occlu-
sion should be above the detection threshold and thus
still elicit a RREP even in the presence of an increased
background resistance [6]. This has however not been
studied specifically, and how a very high load sustained
indefinitely as in our CF patients can modify the RREP
threshold as compared to a resistance detection threshold
is not known. Of note, and even though no statistically
significant trend was detected, some of the CF patients
who completely missed the RREPs were among the
patients with the most severe respiratory mechanics and
respiratory muscle abnormalities (data not shown). That
the RREPs abnormalities observed were dichotomous
(absence of components, but normal latencies and ampli-
tudes of the preserved components) seems to support the
role of the background load. We however acknowledge
that this hypothesis would be have been much strength-
ened if we had demonstrated that our CF patients were
less apt than the other patients to detect added inspiratory
loads. We did not assess this point, and to our knowledge,
there is currently insufficient data to support this hypoth-
esis.
Patients with neuromuscular weakness but without overt
respiratory mechanics abnormalities do not breathe
against increased loads. This is also the case for asthmatic
patients with reversible airway obstruction when they are
in clinical remission, which was the case for all the asth-
matic patients in the present study. Nevertheless we
observed RREPs abnormalities in these two categories of
patients. The "increased background resistance" mecha-
nism is therefore probably not the unique one to call
upon to explain our findings.
Technical explanations, such as differences in skin imped-
ance between control subjects and sick patients in general,
and between CF patients and others in particular, can be
ruled out because we paid careful attention to check and
maintain the impedance of our recording montage as low
as possible in all cases. From a technical point of view, a
greater incidence of the N1 peak than the P1 peak may be
surprising for a pattern of neural activity that has been
reported previously to occur as a linked sequence of neu-
ral events. This may be the result of our exclusive use of
the Cz reference electrode montage. Indeed, the P1 peak
dipole is best modelled in the somatosensory cortex
recorded with electrodes placed 2 cm caudal to the C3 and
C4 sites [23]. The N1 peak is best modelled at the Cz site
using a non-cephalic reference. Our montage was never-
theless able to identify normal RREPs with the full
sequence of components in healthy subjects.
It must also be noted that we did not perform the respira-
tory mechanics and respiratory muscles measurements in
the patients with asthma or a neuromuscular disease. The
absence of abnormalities in these patients is therefore
only assumed, and we may thus have missed an increase
in inspiratory load in some of the participants. Beside this
possibility, patients with weak inspiratory muscles faced
to an inspiratory occlusion develop an inspiratory effort
that is closer to their maximal inspiratory output than
patients exhibiting normal muscle strength. It cannot be
excluded that this interferes in some way with the produc-
tion of the RREPs.
The role of inflammation must also be discussed. Patients
with asthma and CF characteristically exhibit airway
inflammation in the broadest sense of the term, although
the pathophysiology and the course of the inflammatory
process differ between the two diseases. In CF, airway
inflammation occurs early in life, is poorly controlled by
anti-inflammatory drugs, and is closely linked to bacterial
airway infection [24]. In asthma, inflammation can occur
at different ages, can be efficaciously controlled by
inhaled corticosteroids, and is not linked to bacterial air-
way infection [25]. As a result, asthma and CF have radi-
cally different clinical and functional profiles.
Schematically, asthma can be viewed as a chronic disease
featuring episodes of reversible airway obstruction of var-
ious magnitudes. CF is a chronic lung disease character-
ised by a chronic and progressively worsening airway
obstruction. Hyperinflation is early and constant in CF
[20,26], but it is observed only in the most severe asth-
matic patients experiencing poor therapeutic control [27].
Our observation of greater RREPs abnormalities in CF and
asthma children than in children with neuromuscular dis-
ease may suggest that chronic respiratory inflammation
may interfere with the processing of respiratory afferent
information by the brain, whatever the underlying mech-
anism. Indeed the number of CF patients exhibiting no
RREP at all was significantly higher than in any of the
other patient groups studied. Of note, data in the litera-
ture indicate that there may be a relationship between the
brain and airway inflammation [28]. Indeed, it has been
shown in patients with allergic asthma that some brain
regions may be hyperresponsive to disease specific emo-
tional and afferent physiological signals, which may con-
tribute to the dysregulation of peripheral processes, such
as airway inflammation [28].
Clinical perspectives
Our results are not out of line with the observations made
in asthmatic children by Davenport et al. [14]. These
researchers observed that the P1 peak was absent in 6 of
11 patients with life-threatening asthma, whereas it was
present in 14 of the 15 control asthmatic patients and in
all the 14 nonasthmatic patients. Some of the asthmaticRespiratory Research 2007, 8:61 http://respiratory-research.com/content/8/1/61
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patients included in our study had a history of near-fatal
asthma (n = 7), and among them 43% and 57% lacked
the P1 component on the right and the left side, respec-
tively, which fits with the 54% proportion reported by
Davenport et al. [14]. In our study, the presence of RREPs
abnormalities in the asthmatic children having no history
of near-fatal asthma does not agree with the results of
Davenport et al. [14], but this may be explained by differ-
ent population characteristics. To the best of our knowl-
edge, our study is the first to provide RREPs data in
children with CF and with a restrictive ventilatory defect
of neuromuscular origin.
Davenport et al. [14] interpreted their findings within the
frame of the blunted perception of inspiratory load that
has been observed in asthmatic patients with a history of
life-threatening asthma, be they adults [12] or children
[11] for load detection [13] or for load magnitude estima-
tion. Subjacent to this interpretation is the temptation to
use the RREPs as a possible prognostic tool, for example
to identify patients at risk of sudden, unexpected acute
exacerbations of their disease without recognising them.
Clearly the gap to bridge before this can become a reality
is very wide at present. Specifically designed clinical stud-
ies are needed. Our data however open the possibility that
this concept could apply not only to asthma, but also to
other chronic inflammatory respiratory disorders in chil-
dren. The first step to take in the direction of a clinical use
of the RREPs would be, as discussed above, seems to put
this neurophysiological information in the perspective of
a description of the load detection and load magnitude
estimation performances in patients with CF and neu-
romuscular disease. Then putative correlates with clinical
profiles could be sought.
Conclusion
An impaired cortical processing of afferent respiratory sig-
nals, as assessed by the analysis of RREPs, may be
observed in children with chronic ventilatory defects.
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